go back

Gene Test For Skin Squamous Carcinoma Outlook

Delaware rates for HCPCS 0315U

Predicts how likely a cutaneous squamous cell carcinoma, a common skin cancer, is to spread, so that treatment and follow-up can be matched to the risk. Preserved, formalin-fixed tumor tissue is tested by RT-PCR across forty genes: thirty-four that carry the prognostic signal and six reference genes used as controls. The result is reported as a risk class.

Rates data updated July 2026.

How much rates vary

Facilitymedian $9,772 · 10th to 90th $9,772 to $9,772Professionalmedian $4,467 · 10th to 90th $4,467 to $7,079
$5K$10Kfacility $9,772professional $4,467

Distribution of negotiated rates across all payers (price axis is log-scale). Each curve is scaled to its own total: facility and professional rates are different services, shown together to compare where they cluster. Small sample; interpret with caution. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$9,772.37
Median
$9,772.37
Typical High
$9,772.37
Aetna
Setting
Professional
Modifier
Global
Typical Low
$4,466.84
Median
$4,466.84
Typical High
$7,079.46
United
Setting
Professional
Modifier
Global
Typical Low
$3,548.13
Median
$5,128.61
Typical High
$12,882.50